Thrombosis associated with the use of recombinant activated factor VII: Profiling two events

Thrombosis and Haemostasis

Volumn 92, Issue 6, 2004, Pages 1448-1449

  Ng, Heng Joo ^a   Loh, Yvonne S M ^a   Tan, Daryl C L ^a   Lee, Lai Heng ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9 COMPLEX; LIPID; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EDEMA; HEMATOMA; HEMIPLEGIA; HEMOPHILIA A; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

EID: 10444233469     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614303     Document Type: Article

References (10)

1. Kenet G, et al. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354:1879.
2. Herbertson M. Recombinant activated factor VIIa in cardiac surgery. Blood Coagul Fibrinolysis 2004; 15 (Suppl): S31-2.
3. Silva MA, et al. The management of coagulopathy and blood loss in liver surgery. Semin Hematol 2004; 41: 132-9.
4. d'Oiron R, et al. Use of recombinant factor VIIa in 3 patients with inherited type 1 Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 2000; 83: 644-7.
5. Roberts HR, et al. Safety profile of recombinant factor VIIa. Semin Hematol 2004; 41: 101-8.
6. Dargaud Y, et al. Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A. Blood Coagul Fibrinolysis 2003; 14: 407-9.
7. Van der Planken MG, et al. Distal deep venous thrombosis in a haemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion. Blood Coagul Fibrinolysis 2002; 13: 367-70.
8. Aledort LM. Factor IX and thrombosis. Scand J Haematol 1977; 30: 40-2.
9. Keys NS, et al. Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy. Tbromb Haemost 2002; 88: 60-5.
10. Rosenfeld SB, et al. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient. Thromb Haemost 2002; 87: 925.